Log in or Sign up for Free to view tailored content for your specialty!
Practice Management News
FDA authorizes updated COVID-19 booster vaccines
The FDA on Wednesday authorized bivalent COVID-19 booster vaccines from Moderna and Pfizer-BioNTech for emergency use in the United States.
Electronic monitoring can be useful to assess IPF medication nonadherence, timing
Use of electronic monitoring systems helped identify prevalent medication nonadherence in patients with idiopathic pulmonary fibrosis taking pirfenidone, according to data published in ERJ Open Research.
Log in or Sign up for Free to view tailored content for your specialty!
Moderna sues Pfizer, BioNTech over patents related to COVID-19 vaccine
Moderna said Friday that it is filing lawsuits against Pfizer and BioNTech alleging that their COVID-19 messenger RNA vaccine infringes on patents crucial to the development of Moderna's mRNA vaccine.
Pfizer-BioNTech eye authorization of omicron booster for all ages
After requesting emergency use authorization for their omicron-adapted COVID-19 vaccine in people aged 12 years and older, Pfizer and BioNTech said Tuesday they are also working with the FDA on bringing a booster to younger children.
Dexamethasone initiation may prevent post-extubation upper airway obstruction in children
High-dose dexamethasone initiation 12 hours before extubation prevented post-extubation upper airway obstruction in children, according to results of a study published in Annals of the American Thoracic Society.
CDC recommends Novavax’s COVID-19 vaccine for adolescents
The CDC on Monday recommended Novavax’s COVID-19 vaccine for use in adolescents aged 12 to 17 years.
Children’s interstitial lung disease tied to high utilization of health care services
Children’s interstitial lung diseases were associated with high utilization of health care services in European countries and subsequent economic burden on health systems, researchers reported in Thorax.
Walensky criticizes COVID-19 response, announces plan to transform CDC
In an email to staff, CDC Director Rochelle P. Walensky, MD, MPH, was critical of the agency’s response to the COVID-19 pandemic and announced internal changes aimed at improving how it operates.
Study: ‘Ultrashort’ antibiotic course OK for pneumonia with normal oxygenation
Patients with normal oxygenation levels who were treated for possible pneumonia experienced similar outcomes with an “ultrashort” course of antibiotics compared with a longer course, researchers reported recently.
‘Surprising’ number of children hospitalized with COVID-19 have neurologic complications
About 7% of children hospitalized with COVID-19 at major pediatric hospitals in the United States experienced a neurologic complication of some kind, even if they were otherwise healthy, a study in Pediatrics reported.